Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevention of Covid-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions Publisher Pubmed



Moossavi S1, 2, 3 ; Fehr K4, 5, 6 ; Maleki H7, 8 ; Seyedpour S9, 10 ; Keshavarzfathi M11, 12 ; Tabasi F13, 14, 15 ; Heravi M13, 15 ; Sharifian R16, 17, 18 ; Shafiei G19, 20, 21 ; Badihian N22, 23 ; Kelishadi R22, 23 ; Nematollahi S16, 18 ; Almasi M19, 21 ; Popescu S24, 25 Show All Authors
Authors
  1. Moossavi S1, 2, 3
  2. Fehr K4, 5, 6
  3. Maleki H7, 8
  4. Seyedpour S9, 10
  5. Keshavarzfathi M11, 12
  6. Tabasi F13, 14, 15
  7. Heravi M13, 15
  8. Sharifian R16, 17, 18
  9. Shafiei G19, 20, 21
  10. Badihian N22, 23
  11. Kelishadi R22, 23
  12. Nematollahi S16, 18
  13. Almasi M19, 21
  14. Popescu S24, 25
  15. Keshavarzfathi M11, 12
  16. Rezaei N26, 27, 28
Show Affiliations
Authors Affiliations
  1. 1. Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Canada
  2. 2. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Microbiome and Microbial Ecology Interest Group (MMEIG), Universal Scientific Education and Research Network (USERN), Calgary, Canada
  4. 4. Children’s Hospital Research Institute of Manitoba, Winnipeg, MB, Canada
  5. 5. Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada
  6. 6. Microbiome and Microbial Ecology Interest Group (MMEIG), Universal Scientific Education and Research Network (USERN), Winnipeg, MB, Canada
  7. 7. Department of Medical Nanotechnology and Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
  8. 8. Nanomedicine Research Association (NRA), Universal Scientific Education and Research Network (USERN), Kermanshah, Iran
  9. 9. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Nanomedicine Research Association (NRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  11. 11. School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  12. 12. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  13. 13. School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran
  14. 14. Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
  15. 15. Medical Education Development Network (MED_NET), Universal Scientific Education and Research Network (USERN), Zahedan, Iran
  16. 16. Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  17. 17. Iranian Association of Urology, Research Committee (IUA-RC), Tehran, Iran
  18. 18. Urology Research Taskforce (URT), Universal Scientific Education and Research Network (USERN), Tehran, Iran
  19. 19. Gametogenesis Research Center, Kashan University of Medical Sciences, Kashan, Iran
  20. 20. Department of Anatomy, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
  21. 21. Brain Cancer Research Core (BCRC), Universal Scientific Education and Research Network (USERN), Kashan, Iran
  22. 22. Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
  23. 23. Primordial Prevention of Non Communicable Disease Group (PPNCDG), Universal Scientific Education and Research Network (USERN), Isfahan, Iran
  24. 24. HonorHealth, Phoenix, AZ, United States
  25. 25. Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, United States
  26. 26. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  27. 27. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  28. 28. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Stockholm, Sweden

Source: Advances in Experimental Medicine and Biology Published:2021


Abstract

The disease 2019 (COVID-19) made a public health emergency in early 2020. Despite attempts for the development of therapeutic modalities, there is no effective treatment yet. Therefore, preventive measures in various settings could help reduce the burden of disease. In this chapter, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19, non-pharmaceutical approaches at individual and population level, chemoprevention, immunoprevention, preventive measures in different healthcare settings and other professions, special considerations in high-risk groups, and the role of organizations to hamper the psychosocial effects will be discussed. © 2021, The Author(s), under exclusive license to Springer Nature Switzerland AG.
Related Docs
View other Related Docs
1. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)
2. How Covid-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment, Advances in Experimental Medicine and Biology (2021)
3. Computed Tomography Scan in Covid-19: A Systematic Review and Meta-Analysis, Polish Journal of Radiology (2022)
4. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in Covid-19: A Multisystem Disease, Advances in Experimental Medicine and Biology (2021)
5. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
6. How Prevalent Is Cancer in Confirmed Cases With Coronaviruses and Severe Acute Respiratory Syndromes?, Advances in Experimental Medicine and Biology (2021)
7. Covid-19 and Its Global Economic Impact, Advances in Experimental Medicine and Biology (2021)
8. A Borderless Solution Is Needed for a Borderless Complexity, Like Covid-19, the Universal Invader, Advances in Experimental Medicine and Biology (2021)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (89)
Seyed Ahmad Seyed Alinaghi (18)
Other Related Docs
9. Interdisciplinary Approaches to Covid-19, Advances in Experimental Medicine and Biology (2021)
10. Introduction on Coronavirus Disease (Covid-19) Pandemic: The Global Challenge, Advances in Experimental Medicine and Biology (2021)
11. Computational Drug Discovery and Repurposing for the Treatment of Covid-19: A Systematic Review, Bioorganic Chemistry (2021)
12. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation During the Covid-19 Pandemic, Advances in Experimental Medicine and Biology (2021)
13. A Systematic Review of Pregnant Women With Covid-19 and Their Neonates, Archives of Gynecology and Obstetrics (2021)
14. Altered Immunoemotional Regulatory System in Covid-19: From the Origins to Opportunities, Journal of Neuroimmunology (2021)
15. Health Care Policies and Covid-19 Prevalence: Is There Any Association?, International Journal of Health Services (2022)
16. Nutrition and Immunity in Covid-19, Advances in Experimental Medicine and Biology (2021)
17. Covid-19 in Patients With Cancer, Advances in Experimental Medicine and Biology (2021)
18. The Epidemiologic Aspects of Covid-19 Outbreak: Spreading Beyond Expectations, Advances in Experimental Medicine and Biology (2021)
19. Interferon Therapy in Patients With Sars, Mers, and Covid-19: A Systematic Review and Meta-Analysis of Clinical Studies, European Journal of Pharmacology (2021)
20. Health and Art (Heart): Integrating Science and Art to Fight Covid-19, Advances in Experimental Medicine and Biology (2021)
21. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)
22. Biosensing Surfaces and Therapeutic Biomaterials for the Central Nervous System in Covid-19, Emergent Materials (2021)
23. Socialization During the Covid-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing, Advances in Experimental Medicine and Biology (2021)
24. Neurologic Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)
25. Coronavirus: Pure Infectious Disease or Genetic Predisposition, Advances in Experimental Medicine and Biology (2021)
26. Anosmia: A Missing Link in the Neuroimmunology of Coronavirus Disease 2019 (Covid-19), Reviews in the Neurosciences (2020)
27. Microfluidic Devices for Detection of Rna Viruses, Reviews in Medical Virology (2021)
28. Angiotensin-Converting Enzyme 2 (Ace2) Receptor and Sars-Cov-2: Potential Therapeutic Targeting, European Journal of Pharmacology (2020)
29. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
30. Covid-19: Transmission, Prevention, and Potential Therapeutic Opportunities, Clinica Chimica Acta (2020)
31. Regenerative Medicine in Covid-19 Treatment: Real Opportunities and Range of Promises, Stem Cell Reviews and Reports (2021)
32. Remdesivir: A Beacon of Hope From Ebola Virus Disease to Covid-19, Reviews in Medical Virology (2020)
33. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
34. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
35. Targeted Therapy Strategies Against Sars-Cov-2 Cell Entry Mechanisms: A Systematic Review of in Vitro and in Vivo Studies, Journal of Cellular Physiology (2021)
36. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)
37. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
38. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
39. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)
40. Pathophysiology of Covid-19 Infection: What Is the Novel Coronavirus (Sars-Cov-2) Doing to Body? a Comprehensive Systematic Review, Reviews and Research in Medical Microbiology (2021)
41. Sars-Cov-2: From the Pathogenesis to Potential Anti-Viral Treatments, Biomedicine and Pharmacotherapy (2021)
42. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
43. The Situation of Small Molecules Targeting Key Proteins in Combatting Sars-Cov-2: Synthesis, Metabolic Pathway, Mechanism of Action, and Potential Therapeutic Applications, Mini-Reviews in Medicinal Chemistry (2022)
44. Convalescent Plasma Against Covid-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases, Microorganisms (2020)
45. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
46. Serological Tests for Covid-19: Potential Opportunities, Cell Biology International (2021)
47. The Immune System and Covid-19: Friend or Foe?, Life Sciences (2020)
48. Current Treatments and Therapeutic Options for Covid-19 Patients: A Systematic Review, Infectious Disorders - Drug Targets (2022)
49. An Overview on the Treatments and Prevention Against Covid-19, Virology Journal (2023)
50. Death Due to Covid-19 in a Patient With Diabetes, Epilepsy, and Gout Comorbidities, Clinical Case Reports (2020)